Dec 23, 2015 | 2015, Press Releases, Scientific
Philogen is awarded a research grant from “Regione Toscana” for a project focusing on the development of new strategies of Factor V purification for patients in need thereof. POSTER PROGETTO FV-ODNov 9, 2015 | 2015, Past Events
Dario Neri, the co-founder and Chairman of the Scientific Advisory Board presented at the 11th Annual European Antibody Congress in Basel, Switzerland, 9th-11th November. The title of the talk was “Armed Antibodies for the treatment of Cancer and of Chronic...Nov 6, 2015 | 2015, Past Events
Dario Neri, the co-founder and chairman of the scientific advisory board of Philogen will deliver the keynote speech at the First Boston Symposium of Encoded Library Platforms in Boston, 6th November. The title of his presentation will be “Single-Pharmacophore and...Oct 12, 2015 | 2015, Press Releases, Scientific
Philogen is pleased to announce that it has signed a collaborative agreement with Boehringer Ingelheim to investigate novel treatment approaches for Acute Myeloid Leukemia. Siena (Italy), October 12th. (see full Press Release).Sep 27, 2015 | 2015, Past Events
Philogen. Data from Phase Ib clinical trial of Dekavil in rheumatoid arthritis were presented at the 4th Israel-Italy Meeting of Autoimmunity and Autoinflammation: Cutting Edge. Siena (Italy), September 27th-28th.Jun 12, 2015 | 2015, Past Events
Recent Comments